100 Most Influential People in Healthcare - 2019

Ubl and the pharmaceutical industry have been successful in derailing legislative efforts in Congress to curtail drug prices. The industry also fought a Trump administration rule that would have forced drugmakers to post their list prices in television ads. In October, Ubl said if the drug price bill passes Congress, small start-up biopharmaceutical firms that depend on venture capital will vanish.